Showing results (61-70 of 190) with videos related to
Sort By:
Pageof 19
American Journal of Hematology|April 1, 2003
Partially successful treatment of a patient with chronic lymphocytic leukemia and Hodgkin's disease: case report and literature reviewGiridhar U Adiga, Lool Abebe, Peter H WiernikCancer|September 21, 2004
Active chemotherapy for sarcomatoid and rapidly progressing renal cell carcinomaDavid M Nanus, Alexandria Garino, Matthew I Milowsky, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 4, 2014
The leukemias: a half-century of discoveryEmil J Freireich, Peter H Wiernik, David P SteensmaInfectious Agents and Cancer|March 1, 2008
Mouse mammary tumor virus (MMTV)-like DNA sequences in the breast tumors of father, mother, and daughterPolly R Etkind, Alexandre Fr Stewart, Peter H WiernikCancer|October 14, 2005
Phase II study of carboxyamidotriazole in patients with advanced renal cell carcinoma refractory to immunotherapy: E4896, an Eastern Cooperative Oncology Group StudyJanice P Dutcher, Larry Leon, Judith Manola, et al.Hematology (Amsterdam, Netherlands)|July 12, 2008
Leukemic infiltration of the breast in acute lymphocytic leukemia (ALL)Merat Karbasian-Esfahani, Peter H Wiernik, Mrilini Yeddu, et al.Leukemia & Lymphoma|October 30, 2009
Radiation therapy compared with chemotherapy for consolidation of chemotherapy-induced remission of advanced Hodgkin lymphoma: a study by the Eastern Co-operative Oncology Group (E1476) with >20 years follow-upPeter H Wiernik, Fangxin Hong, John H Glick, et al.Medical Oncology (Northwood, London, England)|April 1, 2003
Phase I trial of fludarabine and paclitaxel in non-Hodgkin's lymphomaMuhammad R Abbasi, Joseph A Sparano, Catherine Sarta, et al.Skinmed|March 21, 2007
A complex pattern of melanonychia and onycholysis after treatment with pemetrexed for lung cancerConstantin A Dasanu, Peter H Wiernik, Juan Vaillant, et al.Clinical Genitourinary Cancer|August 15, 2015
Atrasentan in Patients With Advanced Renal Cell Carcinoma: A Phase 2 Trial of the ECOG-ACRIN Cancer Research Group (E6800)Michael A Carducci, Judith Manola, Suresh G Nair, et al.Pageof 19